Views & Analysis

Life sciences marketing has rapidly evolved to mirror that of consumer retail. There are now more ways than

Automating – and optimising – HCP engagement to maximise commercial success

https://pharmaphorum.com/views-and-analysis/automating-and-optimising-hcp-engagement-to-maximise-commercial-success/

Events/ JP Morgan/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

JPM2023: Breakthroughs await, but so do roadblocks

Jonah Comstock cell and gene therapies, clinical trials, fda, IRA, JP Morgan Week, neurology 0 Comment

Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres,

JPM2023: Breakthroughs await, but so do roadblocks

https://pharmaphorum.com/views-and-analysis/jpm2023-breakthroughs-await-but-so-do-roadblocks/

Sales and Marketing/ Views & Analysis/ Views and analysis

Another inside peek into pharma marketing at PM Society learning event

Nicole Raleigh development, leadership, learning, Life Sciences, pharma, PM Society, strategy, The Red Thread 0 Comment

The PM Society’s ‘Is Pharma Marketing built on Straw, Sticks, or Bricks?’ interactive information afternoon, held at The

Another inside peek into pharma marketing at PM Society learning event

https://pharmaphorum.com/views-and-analysis/another-inside-peek-into-pharma-marketing-at-pm-society-learning-event/

Patients/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Why script-to-dispense conversion will take centre stage in 2023

mike.hammerton@pharmaphorum.com patient access, patient adherence, prescriptions, Sales and Marketing 0 Comment

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit

Why script-to-dispense conversion will take centre stage in 2023

https://pharmaphorum.com/views-and-analysis/why-script-to-dispense-conversion-will-take-centre-stage-in-2023/

Sales and Marketing/ Views & Analysis/ Views and analysis

Growing pains: how the pharmaceutical industry can hire and retain talent during industry boom

mike.hammerton@pharmaphorum.com hiring, industry, jobs, pharma, professional development, recruitment, talent 0 Comment

Like many industries, the pharmaceutical labour market has felt and will continue to feel the impacts of the

Growing pains: how the pharmaceutical industry can hire and retain talent during industry boom

https://pharmaphorum.com/views-and-analysis/growing-pains-how-the-pharmaceutical-industry-can-hire-and-retain-talent/

Market Access/ Pharma Market Access/ Sales and Marketing/ Transversal Categories/ Views & Analysis/ Views & Analysis/ Views and analysis

Pharma manufacturing can digitalise its way round the next crisis

mike.hammerton@pharmaphorum.com cost, digitalisation, efficiency, Innovation, manufacturing, medicines, modelling, pharma, pharma manufacturing, workflow 0 Comment

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating

Pharma manufacturing can digitalise its way round the next crisis

https://pharmaphorum.com/views-and-analysis/pharma-manufacturing-can-digitalise-its-way-round-the-next-crisis/

M&A/ Sales and Marketing/ Startups/ Transversal Categories/ Views & Analysis/ Views & Analysis/ Views and analysis

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

mike.hammerton@pharmaphorum.com acquisition, compliance, due diligence, M&A, merger, negotiations, pharma, Regulations, startups, strategy 0 Comment

This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

https://pharmaphorum.com/views-and-analysis/how-to-get-acquisition-ready-a-sellers-guide-to-merger-and-acquisition-in-pharma/

Sales and Marketing/ Sales and Marketing/ Transversal Categories/ Views & Analysis/ Views and analysis

7 commercial, sales, and marketing predictions for 2023

mike.hammerton@pharmaphorum.com 2023 predictions, autmation, Clinical, commercial, data access, digital, HCPs, marketing, Medical, MLR, omnichannel, patient centricity 0 Comment

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and

7 commercial, sales, and marketing predictions for 2023

https://pharmaphorum.com/views-and-analysis/7-commercial-sales-and-marketing-predictions-for-2023/

Sales and Marketing/ Views & Analysis/ Views and analysis

Ten ways to ‘silent-night’ in peace

Oliver Stohlmann Corporate Survival Hacks, digital downtime, emergency cover, holiday, peace, rest, switching off, time off 0 Comment

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life

Ten ways to ‘silent-night’ in peace

https://pharmaphorum.com/views-and-analysis/ten-ways-to-silent-night-in-peace/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login